‘First of its kind’ medication can significantly reduce heart attacks and strokes
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
MedPage Today23h
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Leg muscle may serve as an early warning system for heart failure, study finds
Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...
Endocrinology Advisor2d
Eosinophil Counts May Predict Mortality Risk in AMI
Risk of long-term mortality is independently associated with eosinophil counts 5 to 7 days after onset in patients with acute myocardial infarction.
New study finds lower cardiovascular risk in type 1 diabetes than in type 2 diabetes
A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...
thecardiologyadvisor.com3d
Abelacimab Reduces Bleeding Risk Better Than Rivaroxaban in AF With Stroke Risk
Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.